This has been an amazing year for stocks. From the end of 2023 through Nov. 12, the benchmark S&P 500 index climbed 25% ...

And biotech is progressing in the right direction ... A potential P/E multiple re-rating coupled with good growth prospects ...

We recommend buying CNYA ETF for its diversification, despite high expense ratio and valuation concerns. Read here for an ...

TD Cowen analyst Stacy Ku maintained a Buy rating on scPharmaceuticals (SCPH – Research Report) yesterday and set a price target of ...

Sumeet Bagadia recommends five shares to buy today — Windsor Machines, TTL, Suven Pharma, Paradeep Phosphates, and Windlas Biotech ...

Shares of pharmaceutical giant Amgen (AMGN) are attempting to bounce back after suffering a steep drop of 7.1% yesterday.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

In a report released today, Jason Zemansky from Bank of America Securities maintained a Buy rating on Acumen Pharmaceuticals (ABOS – ...

Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when ...

Rocket Lab stock is on a roll as launch revenue rolls in and a new Neutron rocket promises to grow revenue even more. Rocket ...